Back to medications
Medication monograph
olaparib
PARP InhibitorsAntineoplasticsPoly(ADP-ribose) Polymerase InhibitorsChemotherapeutic Agents
Clinical reference
Product monograph
LYNPARZA- olaparib tablet, film coated
Brands & formulations
Family members
Pricing
Price information
Lynparza
AstraZeneca · 150 mg
60: $7382.84120: $14739.99
Classification
- Chemical class
- PARP Inhibitors
- Clinical class
- Antineoplastics
- Banks class
- Poly(ADP-ribose) Polymerase Inhibitors
- AHFS family
- Chemotherapeutic Agents